Bruce Power declares Lutetium-177 commercial production
Автор: Bruce Power
Загружено: 2022-10-23
Просмотров: 1192
Bruce Power has begun commercial production of Lutetium-177, a targeted radionuclide therapy used to treat neuroendocrine tumours and prostate cancer. This lifesaving medical innovation was completed in partnership with Isogen, ITM and the Saugeen Ojibway Nation
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: